Finding the best way to stop atropine eye drops to minimize rebound myopia: A study on slow, very slow, and sudden cessation of atropine eye drops with lifestyle changes.
Not Applicable
- Conditions
- Health Condition 1: H521- Myopia
- Registration Number
- CTRI/2024/03/063869
- Lead Sponsor
- Sneha Jain
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Magnitude of myopia at least -1D in each eye.
Astigmatism less than 4.5D in each eye.
Documented nonprogressive myopia i.e. 0D and axial length progression less than 0.2mm per year.
Children who are on atropine eye drop therapy at any frequency and various concentration
Exclusion Criteria
Allergic to atropine.
Any comorbidities systemic as well as ocular
Children who have pathological myopia
BCVA less than 20 by 40 and 6 by 24
Axial length more than 26.5mm
OCT macula abnormal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Myopia in diopter (sphere)Timepoint: 13 months
- Secondary Outcome Measures
Name Time Method Axial length in mmTimepoint: 13 months